Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress(®) 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice

Maintaining hematocrit (Hct) levels below 45% can reduce morbidity and mortality in patients with polycythemia vera (PV). A device that patients can use to self-monitor Hct levels could enable timely interventions if Hct levels increase above 45%, and could improve quality of life (QoL). This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovó, Alicia, Baierlein-Leimbach, Claudia, Medri, Cesare, Chanias, Ioannis, Errass, Loreen, Fehr, Theresa, Triemer, Therese, McCarthy-Pontier, Daphne B., Lehmann, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320629/
https://www.ncbi.nlm.nih.gov/pubmed/35887998
http://dx.doi.org/10.3390/jcm11144234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320629/
https://www.ncbi.nlm.nih.gov/pubmed/35887998
http://dx.doi.org/10.3390/jcm11144234

Ejemplares similares